Guidance for substantiating the evidence for beneficial effects of probiotics: Probiotics in chronic inflammatory bowel disease and the functional disorder irritable bowel syndrome

Dirk Haller, Jean Michel Antoine, Stig Bengmark, Paul Enck, Ger T. Rijkers, Irene Lenoir-Wijnkoop

Publikation: Beitrag in FachzeitschriftArtikelBegutachtung

83 Zitate (Scopus)

Abstract

Ulcerative colitis and Crohn's disease, the 2 distinct idiopathic pathologies of inflammatory bowel diseases, are spontaneously relapsing, immunologicallymediated disorders of the gastrointestinal tract. Selected probiotics strains have been proven to be clinically effective in maintaining remission in patients with ulcerative colitis. None of the probiotics thus far tested has been shown to be effective in induction of remission or in maintenance of remission in patients with Crohn's disease. The multispecies probiotics mixture of 8 strains seems effective in the maintenance of remission in pouchitis. Irritable bowel syndrome is a functional bowel disorder manifested by chronic, recurring abdominal pain or discomfort associated with disturbed bowel habit in the absence of structural abnormalities likely to account for these symptoms. Recently conducted appropriately powered studies with different (combinations of) probiotics show positive results on reduction of symptoms, although a considerable placebo effect is also found. Mechanistic studies aimed at pathophysiological mechanisms of inflammatory bowel diseases can identify new targets for probiotic bacteria.

OriginalspracheEnglisch
Seiten (von - bis)690S-697S
FachzeitschriftJournal of Nutrition
Jahrgang140
Ausgabenummer3
DOIs
PublikationsstatusVeröffentlicht - März 2010

Fingerprint

Untersuchen Sie die Forschungsthemen von „Guidance for substantiating the evidence for beneficial effects of probiotics: Probiotics in chronic inflammatory bowel disease and the functional disorder irritable bowel syndrome“. Zusammen bilden sie einen einzigartigen Fingerprint.

Dieses zitieren